Double-Carbapenem Therapy for Carbapenemase-Producing Klebsiella pneumoniae

Ítems similars

• In Vivo Efficacy of Simulated Human Dosing Regimens of Prolonged-Infusion Doripenem against Carbapenemase- Producing Klebsiella pneumoniae
  per: Bulik, Catharine C., et al.
  Publicat: (2010)
• Reply to “Double-Carbapenem Therapy Not Proven To Be More Active than Carbapenem Monotherapy against KPC-Positive Klebsiella pneumoniae”
  per: Bulik, Catharine C., et al.
  Publicat: (2012)
• Comparison of the Activity of a Human Simulated, High-Dose, Prolonged Infusion of Meropenem against Klebsiella pneumoniae Producing the KPC Carbapenemase versus That against Pseudomonas aeruginosa in an In Vitro Pharmacodynamic Model
  per: Bulik, Catharine C., et al.
  Publicat: (2010)
• Effectiveness of a Double-Carbapenem Regimen for Infections in Humans Due to Carbapenemase-Producing Pandrug-Resistant Klebsiella pneumoniae
  per: Giamarellou, Helen, et al.
  Publicat: (2013)
• Comparison of Meropenem MICs and Susceptibilities for Carbapenemase-Producing Klebsiella pneumoniae Isolates by Various Testing Methods
  per: Bulik, Catharine C., et al.
  Publicat: (2010)